SPEG对RyR2的抑制性磷酸化缺失促进心房颤动
该研究探讨SPEG(横纹肌优先表达蛋白激酶)在房颤中的作用。发现阵发性房颤患者心房SPEG蛋白水平及RyR2-S2367磷酸化降低;SPEG心房敲除小鼠房颤易感性增加,S2367A敲入小鼠同样易感,而S2367D敲入小鼠抵抗房颤。结论:SPEG磷酸化抑制RyR2介导的肌浆网钙释放,其减少与房颤相关,S2367位点可能成为房颤治疗新靶点。
要点
- 阵发性房颤患者心房SPEG蛋白水平和RyR2-S2367磷酸化均降低。
- SPEG心房敲除小鼠房颤易感性增加,证实SPEG减少的因果作用。
- RyR2-S2367磷酸化缺失增加房颤易感性,而模拟磷酸化则抵抗房颤。
核心结论
- SPEG磷酸化RyR2-S2367抑制RyR2介导的肌浆网钙释放,与PKA、CaMKII作用相反。
- SPEG水平降低和RyR2-S2367磷酸化减少是阵发性房颤患者的特征。
- S2367磷酸化减少与房颤易感性存在因果关系,调控SPEG或S2367磷酸化可能成为房颤治疗新靶点。
研究设计与样本
- 研究采用人右心房活检(阵发性房颤患者)进行Western blotting。
- 使用腺相关病毒9型生成SPEG心房特异性敲除小鼠。
- 通过心内程序电刺激评估小鼠房颤诱发性,共聚焦钙成像评估心房心肌细胞舒张期钙泄漏。
- 采用磷酸化蛋白质组学和Western blotting测量RyR2磷酸化。
- 利用CRISPR-Cas9生成RyR2-S2367A(磷酸化位点失活)和S2367D(组成性激活)敲入小鼠。
主要发现
- 与窦性心律患者相比,阵发性房颤患者心房活检中SPEG蛋白水平降低。
- SPEG心房特异性敲除小鼠经程序电刺激后起搏诱导的房颤易感性增加,心房心肌细胞钙火花频率增强。
- SPEG心肌细胞敲除小鼠心脏磷酸化蛋白质组学鉴定RyR2-S2367为SPEG的新型激酶底物。
- 阵发性房颤患者中RyR2-S2367磷酸化也降低。
- RyR2-S2367A小鼠起搏诱导的房颤易感性增加且心房肌浆网钙泄漏异常,而RyR2-S2367D小鼠抵抗起搏诱导的房颤。
临床怎么用
- SPEG水平和RyR2-S2367磷酸化降低可作为阵发性房颤的分子特征。
- 调控SPEG活性或RyR2-S2367磷酸化水平可能成为房颤治疗的新策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enhanced diastolic calcium (Ca2+) release through ryanodine receptor type-2 (RyR2) has been implicated in atrial fibrillation (AF) promotion. Diastolic sarcoplasmic reticulum Ca2+ leak is caused by increased RyR2 phosphorylation by PKA (protein kinase A) or CaMKII (Ca2+/calmodulin-dependent kinase-II) phosphorylation, or less dephosphorylation by protein phosphatases. However, considerable controversy remains regarding the molecular mechanisms underlying altered RyR2 function in AF. We thus aimed to determine the role of SPEG (striated muscle preferentially expressed protein kinase), a novel regulator of RyR2 phosphorylation, in AF pathogenesis. METHODS: Western blotting was performed with right atrial biopsies from patients with paroxysmal AF. SPEG atrial knockout mice were generated using adeno-associated virus 9. In mice, AF inducibility was determined using intracardiac programmed electric stimulation, and diastolic Ca2+ leak in atrial cardiomyocytes was assessed using confocal Ca2+ imaging. Phosphoproteomics studies and Western blotting were used to measure RyR2 phosphorylation. To test the effects of RyR2-S2367 phosphorylation, knockin mice with an inactivated S2367 phosphorylation site (S2367A) and a constitutively activated S2367 residue (S2367D) were generated by using CRISPR-Cas9. RESULTS: Western blotting revealed decreased SPEG protein levels in atrial biopsies from patients with paroxysmal AF in comparison with patients in sinus rhythm. SPEG atrial-specific knockout mice exhibited increased susceptibility to pacing-induced AF by programmed electric stimulation and enhanced Ca2+ spark frequency in atrial cardiomyocytes with Ca2+ imaging, establishing a causal role for decreased SPEG in AF pathogenesis. Phosphoproteomics in hearts from SPEG cardiomyocyte knockout mice identified RyR2-S2367 as a novel kinase substrate of SPEG. Western blotting demonstrated that RyR2-S2367 phosphorylation was also decreased in patients with paroxysmal AF. RyR2-S2367A mice exhibited an increased susceptibility to pacing-induced AF, and aberrant atrial sarcoplasmic reticulum Ca2+ leak, as well. In contrast, RyR2-S2367D mice were resistant to pacing-induced AF. CONCLUSIONS: Unlike other kinases (PKA, CaMKII) that increase RyR2 activity, SPEG phosphorylation reduces RyR2-mediated sarcoplasmic reticulum Ca2+ release. Reduced SPEG levels and RyR2-S2367 phosphorylation typified patients with paroxysmal AF. Studies in S2367 knockin mouse models showed a causal relationship between reduced S2367 phosphorylation and AF susceptibility. Thus, modulating SPEG activity and phosphorylation levels of the novel S2367 site on RyR2 may represent a novel target for AF treatment.
引用
- Campbell HM, Quick AP, Abu-Taha I, et al. Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation. Circulation. 2020. PMID: 32683896. doi:10.1161/CIRCULATIONAHA.120.045791
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。